Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca Amarin-to-Forest Deal Seen on Lost Patents: Real M&A
Bloomberg
Wednesday, April 25, 2012 - 10:32am
tags:
Amarin, Forest Labs, patents, M&A, AstraZeneca, Ardea
Yet Another Delay for Forest Labs
Yahoo/Zacks
Wednesday, April 25, 2012 - 10:31am
tags:
Forest Labs, Ironwood Pharmaceuticals, linaclotide, irritable bowel syndrome
Botox ingredient has limited effect on headaches -study
Reuters
Wednesday, April 25, 2012 - 10:30am
tags:
Botox, migraines, Allergan
Glaxo Quarterly Profit Misses Estimates on Europe Sales
Bloomberg
Wednesday, April 25, 2012 - 10:28am
tags:
GSK, earnings
Amgen buying Turkish pharmaceutical company Mustafa Nevzat Pharmaceuticals for $700 million
Yahoo/AP
Wednesday, April 25, 2012 - 10:27am
tags:
Mustafa Nevzat, Turkey, Amgen, M&A
Lpath Receives First U.S. Patent for Anti-LPA Antibody, Lpathomab
Yahoo
Wednesday, April 25, 2012 - 10:26am
tags:
Lpath, patents, anti-LPA antibodies, Lpathomab
MannKind: Will The Good News Ever Come?
Seeking Alpha
Wednesday, April 25, 2012 - 10:25am
tags:
MannKind, Afrezza, inhaled insulin, diabetes
Targacept cuts 46 pct jobs, to focus on key drugs
Reuters
Wednesday, April 25, 2012 - 10:24am
tags:
layoffs, Targacept
Drug Companies in M&A Rush
WSJ Online
Wednesday, April 25, 2012 - 10:24am
tags:
M&A, Watson Pharmaceuticals, Actavis, Ardea, AstraZeneca, Roche, Illumina, GSK, Human Genome Sciences
Pfizer Will Surge Above $22 High On Strong Drug Portfolio
Seeking Alpha
Wednesday, April 25, 2012 - 10:21am
tags:
Pfizer, Abbott Laboratories, GSK, Merck, Nestle
How the FDA Stifles New Cures, Part I: The Rising Cost of Clinical Trials
Forbes
Wednesday, April 25, 2012 - 10:20am
tags:
FDA, innovation, clinical trials
Amgen Posts Strong Drug Sales, Beats Estimates
Barron's
Wednesday, April 25, 2012 - 10:19am
tags:
Amgen, earnings
Glaxo Plays Hardball With Human Genome Sciences
Investopedia.com
Wednesday, April 25, 2012 - 10:18am
tags:
GSK, Human Genome Sciences, M&A
Lilly sales, profit beat forecasts
Reuters
Wednesday, April 25, 2012 - 10:17am
tags:
earnings, Eli Lilly
Two Hepatitis C Treatments Win U.K. Health-Cost Agency Backing
Bloomberg
Wednesday, April 25, 2012 - 10:17am
tags:
hepatitis C, Victrelis, Merck, UK, JNJ, Incivo
Earnings Preview: Merck Reports Results Friday
Seeking Alpha
Wednesday, April 25, 2012 - 10:16am
tags:
Merck, earnings
Questcor Earnings Seen Again Rising By Triple Digits
Investors.com
Tuesday, April 24, 2012 - 11:21am
tags:
Questcor, earnings
Bristol-Myers Squibb: Earnings Preview
Seeking Alpha
Tuesday, April 24, 2012 - 11:19am
tags:
earnings, Bristol-Myers Squibb
Merck First Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Tuesday, April 24, 2012 - 10:42am
tags:
Merck, earnings
Watson, Actavis to Merge in €4.5 Billion Deal
WSJ Online
Tuesday, April 24, 2012 - 10:40am
tags:
Watson, Actavis, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.